Search results

Selected filters:

North America
Strategy

Article type

Topic

Sector

Jurisdictions

1,004 results found for your search

Sort options
16 January 2020

Breaking: EPO Board of Appeal upholds invalidation of Broad’s CRISPR-Cas9 patent

Surprise move means Enlarged Board will not now be asked to consider key questions that were referred to it yesterday

16 January 2020

Viability of sham litigation suits on the line in AbbVie appeal

The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

07 January 2020

ITC cases were more China-focused than ever in 2019

But study by Chinese trade body shows that respondents who fight back do surprisingly well

07 January 2020

Federal Circuit delivers good news for process patent owners

A precedential decision last month makes it easier for rights holders to assert successfully against imported products

06 January 2020

Xiaomi, HP among eleventh-hour MPEG-LA HEVC licensees

Nineteen companies in all took the chance to secure rights to the portfolio before a contingent of South Korean and Japanese patent owners departed the pool last Thursday

03 January 2020

Huawei to join HEVC Advance in first major pool sign-up

Previously unaffiliated, the Chinese company is set to come on board as a licensor and licensee

02 January 2020

Why the traditional US model of educating tomorrow’s lawyers must change

Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean

20 December 2019

Jury awards $752 million in dispute over cutting-edge CAR-T technology

The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.

19 December 2019

Oblon McClelland Maier & Neustadt revealed as number one filer for the IAM/ktMINE US Patent Elite

Arlington-based firm acts for more of the companies that own the biggest US portfolios than any other, with Foley & Lardner and Harness Dickey & Pierce rounding out the top three

19 December 2019

TCS: Current IP paradigm inadequate for the age of AI

IT giant Tata Consultancy Services urges policymakers around the world to clarify and harmonise IP policies in new report

18 December 2019

Microsoft appoints new head of IP

Jennifer Yokoyama previously led the company's IP litigation team and replaces Erich Andersen, whose departure was announced last week

17 December 2019

US NPE leverages China litigation to secure Xiaomi deal

Acacia sub-licensor scored a global deal with smartphone maker as key rights neared expiration

13 December 2019

LOT’s expanding membership in China indicates rising NPE worry

In addition to the big names, defensive network is attracting China-focused companies that have never faced assertion in US courts 

10 December 2019

How the threat of unsold rights, the rise of the in-house dealmaker and a revolution in analytics are re-shaping the IP deals market

As IAM releases this year's brokered patent market survey one of its authors digs deep into the current climate for transactions and explains why some of the grunt work of five years ago is a thing of the past